Operating Lease, Right-of-Use Asset in USD of China SXT Pharmaceuticals, Inc. from Q1 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
China SXT Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2023 to Q1 2025.
  • China SXT Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $177K, a 25.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $177K -$59.2K -25.1% 31 Mar 2025 20-F 31 Jul 2025
Q3 2024 $213K 30 Sep 2024 6-K 28 Mar 2025
Q1 2024 $236K -$70.2K -22.9% 31 Mar 2024 20-F 31 Jul 2025
Q1 2023 $306K 31 Mar 2023 20-F 31 Jul 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.